IRD Q4 2022 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$40M

Gross Profit

$40M100.0% margin

Operating Income

$34M85.8% margin

Net Income

$34M85.2% margin

EPS (Diluted)

$1.58

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$29M

Stock-Based Comp.

$424,000

Balance Sheet

Total Assets

$49M

Total Liabilities

$3M

Stockholders' Equity

$46M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$0	—
Gross Profit	$40M	$0	—
Operating Income	$34M	-$6M	+656.3%
Net Income	$34M	-$6M	+637.6%